Studies on the mechanism of the antilipolytic effect of Paraoxon.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000262:Adenylyl Cyclases; D000273:Adipose Tissue / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D000818:Animals; D000931:Antidotes / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D007306:Insecticides / Q000494:pharmacology*; D050356:Lipid Metabolism; D008297:Male; D010091:Oximes / Q000494:pharmacology; D010261:Paraoxon / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D010759:Phosphorus Isotopes; D010770:Phosphotransferases / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D051381:Rats; D014316:Tritium
D000931:Antidotes; D002800:Cholinesterase Inhibitors; D007306:Insecticides; D010091:Oximes; D010759:Phosphorus Isotopes; D011506:Proteins; D014316:Tritium; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D010770:Phosphotransferases; D010727:Phosphoric Diester Hydrolases; D000262:Adenylyl Cyclases; D010261:Paraoxon